The hair physician should coordinate with the clinician prescribing the GLP-1 therapy
5 While its primary endpoint (a composite including all-cause mortality, nonfatal MI, stroke, acute coronary syndrome, leg revascularization, and major leg amputation) did not reach significance, a main secondary composite endpoint (all-cause mortality, nonfatal MI, and stroke) showed a significant benefit with pioglitazone (hazard ratio [HR] 0.84
While semaglutide has been used for more than 15 years to treat Type 2 diabetes, there are brands of semaglutide that are FDA approved for weight loss as well
Lancet (2024) 403(10431):102750
Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline bmi or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
PlexusDx providers can help you start with either medication and adjust based on your real-world response